Special Design for Astaxanthin Factory from Victoria
Special Design for Astaxanthin Factory from Victoria Detail:
[Latin Name] Haematococcus Pluvialis
[Plant Source] from China
[Specifications]1% 2% 3% 5%
[Appearance] Dark red Powder
[Particle size] 80 Mesh
[Loss on drying] ≤5.0%
[Heavy Metal] ≤10PPM
[Storage] Store in cool & dry area, keep away from the direct light and heat.
[Shelf life] 24 Months
[Package] Packed in paper-drums and two plastic-bags inside.
[Net weight] 25kgs/drum
Brief Introduction
Astaxanthin is a natural nutritional component, it can be found as a food supplement. The supplement is intended for human, animal, and aquaculture consumption.
Astaxanthin is a carotenoid. It belongs to a larger class of phytochemicals known as terpenes, which are built from five carbon precursors; isopentenyl diphosphate and dimethylallyl diphosphate . Astaxanthin is classified as a xanthophyll (originally derived from a word meaning “yellow leaves” since yellow plant leaf pigments were the first recognized of the xanthophyll family of carotenoids), but currently employed to describe carotenoid compounds that have oxygen-containing moities, hydroxyl or ketone , such as zeaxanthin and canthaxanthin. Indeed, astaxanthin is a metabolite of zeaxanthin and/or canthaxanthin, containing both hydroxyl and ketone functional groups. Like many carotenoids, astaxanthin is a colorful, lipid-soluble pigment. This colour is due to the extended chain of conjugated (alternating double and single) double bonds at the centre of the compound. This chain of conjugated double bonds is also responsible for the antioxidant function of astaxanthin (as well as other carotenoids) as it results in a region of decentralized electrons that can be donated to reduce a reactive oxidizing molecule.
Function:
1.Astaxanthin is a powerful antioxidant and may protect against oxidative damage to body tissues.
2.Astaxanthin can improve the immune response by increasing the number of antibody producing cells.
3.Astaxanthin is a potential candidate to treat neurodegenerative disease such as Alzhimer and Parkinson diease.
4.Astaxanthin dan reduce UVA-light damage to skin such as sunburn, inflammation, ageing and skin cancer.
Application
1.When applied in pharmaceutical field, astaxanthin powder has the good function of antineoplastic;
2.When applied in health food field, astaxanthin powder is used as food additives for pigment and health care;
3.When applied in cosmetic field, astaxanthin powder has the good function of antioxidant and anti-aging;
4.When applied in animal feeds field, astaxanthin powder is used as animal feed additive to impart coloration, including farm-raised salmon and egg yolks.
Product detail pictures:

Related Product Guide:
We insist on the principle of development of 'High quality, Efficiency, Sincerity and Down-to-earth working approach' to deliver you with great provider of processing for Special Design for Astaxanthin Factory from Victoria , The product will supply to all over the world, such as: Belize, Saudi Arabia, Thailand, To win customers' confidence, Best Source has set up a strong sales and after-sales team to provide the best product and service. Best Source abides by the idea of "Grow with customer" and philosophy of "Customer-oriented" to achieve cooperation of mutual trust and benefit. Best Source will always stand ready to cooperate with you. Let's grow together!
Taking the natural herbal sex pills to get bigger penis and doing better sexual performance.
medskl.com is a global, free open access medical education (FOAMEd) project covering the fundamentals of clinical medicine with animations, lectures and concise summaries. medskl.com is working with over 170 award-winning medical school professors to provide content in 200+ clinical presentations for use in the classroom and for physician CME.
Primary Care – Infant and Child Immunization
Whiteboard Animation Transcript
with David Scheifele, MD
https://medskl.com/Module/Index/infant-and-child-immunization
Modern vaccines are safe and impressively effective, potentially eliminating circulation of most target infections. Immunization allows for protection against a broad range of infections.
During pregnancy, transplacental passage of maternal IgG antibodies allows for passive protection in the first 6 months of life. This, however, decays rapidly, with little remaining beyond 6 months of age. Thus, early infancy is the ideal time to begin immunization so that active immunity can replace waning passive protection without a period of vulnerability in between.
To achieve this goal, infants typically require several initial vaccine doses spaced about 8 weeks apart, known as the primary series. It ensures that their immature immune system responds adequately. Adherence to the schedule minimizes infection risks. Depending on the vaccine, a booster dose may be required in the second year of life to reinforce the antibody response and extend protection throughout early childhood; additional booster doses may be needed at 4-6 years and in adolescence to renew and extend protection.
Immunization schedules vary to some extent across regions and you should become familiar with the schedule used in your region of practice.
As clinicians, you will often get asked about the safety profiles of childhood vaccines. In general, almost all of these vaccines are well tolerated and cause very mild side effects, such as injection site pain or transient fever. The tangible risks are febrile seizures and hypotonic (fainting) spells, which both have low risk rates and benign outcomes.
This table lists some of the rare complications associated with vaccines.
MMR meningitis is mainly attributable to the mumps component and differs among products, being very unlikely with the vaccines used in Canada. Measles encephalitis is a great rarity, seen in a few immunocompromised vaccinees.
Lastly, presence of certain health conditions will alter immunization recommendations. Children at high risk for invasive pneumococcal infection should get 3 primary doses of the PCV13 vaccine (instead of 2) and should also receive the 23-valent pneumococcal polysaccharide vaccine after age 2, which is not part of the routine schedule. Immunocompromised children should not receive live attenuated vaccines.

Goods just received, we are very satisfied, a very good supplier, hope to make persistent efforts to do better.
